Roles of SPARC in urothelial carcinogenesis, progression and metastasis

Neveen Said

doi:10.18632/oncotarget.11590

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Reviews:

Roles of SPARC in urothelial carcinogenesis, progression and metastasis

Neveen Said _

PDF | HTML | How to cite

Oncotarget. 2016; 7:67574-67585. https://doi.org/10.18632/oncotarget.11590

Metrics: PDF 2001 views | HTML 3712 views | ?

Abstract

Neveen Said1

1 Department of Cancer Biology, Wake Forest University Health Sciences, Winston Salem, NC, USA

Correspondence to:

Neveen Said, email:

Keywords: SPARC, urinary bladder, carcinogenesis, cell cycle, inflammation

Received: April 01, 2016 Accepted: July 27, 2016 Published: August 24, 2016

Abstract

Secreted Protein Acidic and Rich in Cysteine (SPARC) is a matricellular glycoprotein that is implicated in myriad physiological and pathological conditions characterized by extensive remodeling and plasticity. The functions and disease association of SPARC in cancer is being increasingly appreciated as it plays multi-faceted contextual roles depending on the cancer type, cell of origin and the unique cancer milieu at both primary and metastatic sites. Herein we will review our current knowledge of the role of SPARC in the multistep cascades of urinary bladder carcinogenesis, progression and metastasis from preclinical models and clinical data and shine the light on its prognostic and therapeutic potentials.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 11590

Publication Alerts

Post-Publication Promotion

Publication Discount

Reviews:

Roles of SPARC in urothelial carcinogenesis, progression and metastasis

Abstract